News
Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
WITH the price of Mounjaro set to rise and concerns about long-term affordability and access, many may be looking to turn to ...
Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed ...
The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...
The weight-loss drug Wegovy just got FDA approval to treat a common and serious liver condition known as MASH (Metabolic ...
CheqUp said it had experienced a spike in interest from consumers wanting to switch or begin taking the medication ...
Key Takeaways Novo Nordisk's blockbuster weight-loss drug, Wegovy, received Food and Drug Administration approval to treat a ...
11hon MSN
The battle of the weight-loss drugs
Can Novo Nordisk and Eli Lilly regain their former stock market glory? A lot is riding on next year's pills ...
1don MSNOpinion
Voices: Yes, Mounjaro is set to treble in price – but don’t abandon weight-loss jabs until you read this
COMMENT: The monthly cost of a private prescription exceeding £300 from next month is worrying news for the half a million ...
The launch marked Danish drugmaker Novo Nordisk's debut on the continent, ramping up competition with rival Eli Lilly.
A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results